Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G KETTLE

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
ACS Medicinal Chemistry Letters|May 15, 2024
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFRNils Pemberton, Nina Compagne, Argyrides Argyrou, et al.
European Journal of Nuclear Medicine|April 16, 1998
Iodine-123 salmon calcitonin, an imaging agent for calcitonin receptors: synthesis, biodistribution, metabolism and dosimetry in humansP J Blower, M R Puncher, A G Kettle, et al.
Nuclear Medicine Communications|June 1, 1995
Ventilation and perfusion lung imaging--which nebulizer?N J Carter, C N Eustance, A G Kettle, et al.
Angewandte Chemie (International Ed. in English)|October 18, 2024
Site-Specific Quadruple-Functionalised AntibodiesToby Journeaux, Michael B Geeson, Thomas V Murray, et al.
Toxicology Research|May 27, 2025
Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidatesSara Amberntsson, Alison J Foster, Bhavik Chouhan, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol seriesBernard Barlaam, Richard Ducray, Christine Lambert-van der Brempt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidismS F Barrington, P Anderson, A G Kettle, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidinesCatherine Bardelle, Darren Cross, Sara Davenport, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2005
5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinasePeter Ballard, Robert H Bradbury, Laurent F A Hennequin, et al.
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|May 15, 2024
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFRNils Pemberton, Nina Compagne, Argyrides Argyrou, et al.
European Journal of Nuclear Medicine|April 16, 1998
Iodine-123 salmon calcitonin, an imaging agent for calcitonin receptors: synthesis, biodistribution, metabolism and dosimetry in humansP J Blower, M R Puncher, A G Kettle, et al.
Nuclear Medicine Communications|June 1, 1995
Ventilation and perfusion lung imaging--which nebulizer?N J Carter, C N Eustance, A G Kettle, et al.
Angewandte Chemie (International Ed. in English)|October 18, 2024
Site-Specific Quadruple-Functionalised AntibodiesToby Journeaux, Michael B Geeson, Thomas V Murray, et al.
Toxicology Research|May 27, 2025
Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidatesSara Amberntsson, Alison J Foster, Bhavik Chouhan, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol seriesBernard Barlaam, Richard Ducray, Christine Lambert-van der Brempt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidismS F Barrington, P Anderson, A G Kettle, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidinesCatherine Bardelle, Darren Cross, Sara Davenport, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2005
5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinasePeter Ballard, Robert H Bradbury, Laurent F A Hennequin, et al.
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Pageof 8